Double‐blind, triple‐crossover trial of low doses of oral physostigmine in inherited ataxias

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Neurology

• Publication date

  1981-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/WNL.31.3.288PMID 7010207
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical correlations of partial deficiency of lipoamide dehydrogenase

  1979cited by this paper
• Studies of the pathophysiology of pyruvate dehydrogenase deficiency.

  1978cited by this paper
• Action of physostigmine on inherited ataxias.

  1978cited by this paper
• Physostigmine in familial ataxias

  1977cited by this paper
• [Familial olivo-ponto-cerebellar atrophy with myoclonus. Limits of cerebellar myoclonic dyssynergia (Ramsay-Hunt syndrome)].

  1976cited by this paper
• Cholinergic-anticholinergic antagonism in parkinsonism.

  1967cited by this paper

• Pharmacological inhibition of acetylcholinesterase improves the locomotion defective phenotype of a SCA3 C. elegans model

  2024cites this paper
• Pretreatment of rhesus monkeys with transdermal patches containing physostigmine and procyclidine: implications of the delivery system for the potential application against VX nerve agent intoxication in humans

  2023cites this paper
• Cerebellar ataxia.

  2018cites this paper
• Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders.

  2018cites this paper
• Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxia

  2018cites this paper
• Regulation of Gait and Balance: The Underappreciated Role of Neuronal Nicotinic Receptor Agonists.

  2016cites this paper
• Emerging therapies in Friedreich's ataxia.

  2016influential citation
• Treatment of cerebellar ataxia.

  2014cites this paper
• Role for the nicotinic cholinergic system in movement disorders; therapeutic implications.

  2014cites this paper
• Neuronal nicotinic receptor agonists improve gait and balance in olivocerebellar ataxia.

  2013cites this paper
• Ataxia cerebelar hereditária autissômica dominante

  2013cites this paper
• Neurochemistry and Neuropharmacology of the Cerebellar Ataxias

  2012cites this paper
• Treatment and management issues in ataxic diseases.

  2012cites this paper
• Friedreich ataxia.

  2012cites this paper
• Therapeutic Interventions in the Primary Hereditary Ataxias

  2010cites this paper
• Effectiveness and safety of treatments for degenerative ataxias: A systematic review

  2009cites this paper
• Subjective improvement in proprioception in 2 patients with atypical Friedreich ataxia treated with varenicline (Chantix).

  2009cites this paper
• Pharmacologic Treatment of Tremor

  2008cites this paper
• Pharmacological treatments of cerebellar ataxia

  2008cites this paper
• Friedreich's ataxia

  2006cites this paper
• Motor Disabilities and Effects of Thyrotropin-Releasing Hormone Spinocerebellar Degeneration

  2006cites this paper
• Friedreich ataxia.

  2003cites this paper
• Cerebellar ataxia

  2000cites this paper
• Friedreich's Ataxia: Clinical Aspects and Pathogenesis

  1999cites this paper
• Die Behandlung von zerebellären Tremorformen und Ataxie

  1998cites this paper
• Double-blind crossover study with physostigmine in patients with degenerative cerebellar diseases.

  1997cites this paper
• International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology.

  1997cites this paper
• [Physostigmine in treatment of cerebellar ataxia].

  1996cites this paper
• Pharmacokinetics of physostigmine in man following a single application of a transdermal system.

  1995cites this paper
• [Theoretical basis and proposals for neuropharmacology of cerebellar ataxia].

  1993cites this paper
• Diseases of the Spinal Cord

  1992cites this paper
• Hereditary and Nutritional Disorders of the Spinal Cord

  1992cites this paper
• Cerebrospinal fluid as a reflector of central cholinergic and amino acid neurotransmitter activity in cerebellar ataxia.

  1990cites this paper
• Oral thyrotropin-releasing hormone treatment in inherited ataxias.

  1988cites this paper
• Neuropharmacological Intervention with Motor System Aging

  1988cites this paper
• Discussion of the Paper

  1988cites this paper
• Drug Treatment of Hyperkinetic Movement Disorders

  1987cites this paper
• Recent advances in the treatment of cerebellar ataxias.

  1986cites this paper
• Clinical Studies of the Cholinergic Deficit in Alzheimer's Disease

  1985cites this paper
• Oral physostigmine treatment of patients with Alzheimer's disease.

  1985cites this paper
• Central hypoventilation syndrome in pyruvate dehydrogenase complex deficiency.

  1984cites this paper
• A theory of the functional organization of the neostriatum and the neostriatal control of voluntary movement.

  1983cites this paper
• Motor disabilities and effects of thyrotropin-releasing hormone on ataxia of spinocerebellar degeneration.

  1983cites this paper
• Controlled trial of thyrotropin releasing hormone tartrate in ataxia of spinocerebellar degenerations.

  1983cites this paper
• Characteristics of Gait Ataxia in Spinocerebellar Degeneration Assessed by Means of Simple Quantitative Method

  1982cites this paper
• Subject index to volume XXXI

  1981cites this paper